Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2016-000238-23Phase 4Completed
Phase 4 trial of exenatide in obesity and dyslipidemia, sponsored by Leiden University Medical Center. Primary endpoint: Primary - BAT volume and activity. Started Jul 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2016-000238-23.